Exact Sciences has increased the size of its board to 10 directors and appointed Michael Wyzga to fill the spot. Wyzga will serve as a Class III director and be on Exact's audit committee until the firm's 2015 annual meeting. Between 2011 and 2013, he was the president and CEO of Radius Health, where he was also a board member. Prior to that, he held various management positions at Genzyme. Wyzga currently is a director at Akebia Therapeutics and Oncomed Pharmaceuticals.